Anterogen.Co.Ltd (065660) — Cash Flow Quality Index

Latest as of March 2023: -7.10x

Anterogen.Co.Ltd (065660) has a Cash Flow Quality Index of -7.10x as of March 2023. Operating cash flow of ₩-265.11 Million is below net income of ₩37.35 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Anterogen.Co.Ltd cash conversion from operations to assess how effectively this company generates cash.

Cash Flow Quality Index

-7.10x
Operating CF / Net Income

Operating Cash Flow

₩-265.11 Million
KRW

Net Income

₩37.35 Million
KRW

Data as of

Mar 2023
Most recent filing

Anterogen.Co.Ltd Cash Flow Quality Index (2016–2017)

Historical Cash Flow Quality Index for Anterogen.Co.Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Anterogen.Co.Ltd to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Anterogen.Co.Ltd (2016–2017)

Year-by-year earnings quality comparison for Anterogen.Co.Ltd. For live market cap and the full company financial profile, see market value of Anterogen.Co.Ltd.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2017 0.85x ₩379.21 Million ₩446.74 Million ▲ +341.5%
2016 -0.35x ₩-130.65 Million ₩371.66 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.